Vestal Point Capital’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Other funds holding UTHR
ACA
JT
Vestal Point Capital's UTHR Position: Q2 2026 in Review
Vestal Point Capital increased its United Therapeutics (UTHR) stake by 480% in Q2 2026, buying an estimated $203M and bringing the position to 435,000 shares worth $236M. The position accounts for 5.51% of the portfolio, ranked #4.
Vestal Point Capital first reported a position in UTHR in Q1 2026 and has held it in 2 quarters since. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- Vestal Point Capital held 435,000 shares of United Therapeutics worth $236M as of Q2 2026.
- Vestal Point Capital bought 360,000 United Therapeutics shares in Q2 2026, an estimated $203M.
- United Therapeutics made up 5.51% of Vestal Point Capital's portfolio in Q2 2026, its #4 holding.
- Vestal Point Capital first reported a position in United Therapeutics in Q1 2026 and has held it in 2 quarters since.
- 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on Vestal Point Capital's 13F filing for Q2 2026, filed 14 Aug 2026.